Lynx1 Capital Management LP Diversified Active

CIK: 0001910456 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $266,711 (100.0% shares, 0.0% debt)

Holdings (18)

— MERUS N V 24.9%

Value ($000) $66,474 Shares 1,580,841 Est. Cost $36.34 Unrealized —

STOK STOKE THERAPEUTICS INC 21.5%

Value ($000) $57,215 Shares 5,187,191 Est. Cost $7.94 Unrealized +54.8%

GHRS GH RESEARCH PLC 12.8%

Value ($000) $34,013 Shares 4,858,994 Est. Cost $9.04 Unrealized -11.1%

CCCC C4 THERAPEUTICS INC 9.2%

Value ($000) $24,670 Shares 6,852,744 Est. Cost $4.53 Unrealized +9.8%

ALLO ALLOGENE THERAPEUTICS INC 8.7%

Value ($000) $23,163 Shares 10,874,723 Est. Cost $2.64 Unrealized -6.5%

TCRX TSCAN THERAPEUTICS INC 6.1%

Value ($000) $16,286 Shares 5,357,347 Est. Cost $2.72 Unrealized +66.3%

CGEM CULLINAN THERAPEUTICS INC 5.7%

Value ($000) $15,320 Shares 1,257,795 Est. Cost $16.54 Unrealized -13.1%

KROS KEROS THERAPEUTICS INC 3.2%

Value ($000) $8,612 Shares 544,001 Est. Cost $51.97 Unrealized 0.0%

— PASSAGE BIO INC 2.0%

Value ($000) $5,250 Shares 9,256,953 Est. Cost $1.03 Unrealized —

— ALLAKOS INC 1.6%

Value ($000) $4,390 Shares 3,628,144 Est. Cost $1.21 Unrealized —

UPB UPSTREAM BIO INC 1.5%

Value ($000) $3,946 Shares 240,042 Est. Cost $22.33 Unrealized 0.0%

DTIL PRECISION BIOSCIENCES INC 1.1%

Value ($000) $2,919 Shares 766,051 Est. Cost $7.30 Unrealized 0.0%

IBIO IBIO INC 0.8%

Value ($000) $2,113 Shares 862,279 Est. Cost $1.77 Unrealized +44.8%

CRBU CARIBOU BIOSCIENCES INC 0.4%

Value ($000) $1,082 Shares 680,189 Est. Cost $2.05 Unrealized -1.8%

— VOR BIOPHARMA INC 0.3%

Value ($000) $707 Shares 637,218 Est. Cost $1.11 Unrealized —

CNTA CENTESSA PHARMACEUTICALS PLC 0.1%

Value ($000) $291 Shares 17,400 Est. Cost $11.30 Unrealized —

NEUP NEUPHORIA THERAPEUTICS INC 0.1%

Value ($000) $157 Shares 45,806 Est. Cost $3.53 Unrealized 0.0%

— REPARE THERAPEUTICS INC 0.0%

Value ($000) $104 Shares 79,176 Est. Cost $1.31 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	MERUS N V	1,580,841	$66,474	24.9%	$36.34	—	COM	N5749R100
STOK	STOKE THERAPEUTICS INC	5,187,191	$57,215	21.5%	$7.94	+54.8%	COM	86150R107
GHRS	GH RESEARCH PLC	4,858,994	$34,013	12.8%	$9.04	-11.1%	ORDINARY SHARES	G3855L106
CCCC	C4 THERAPEUTICS INC	6,852,744	$24,670	9.2%	$4.53	+9.8%	COM STK	12529R107
ALLO	ALLOGENE THERAPEUTICS INC	10,874,723	$23,163	8.7%	$2.64	-6.5%	COM	019770106
TCRX	TSCAN THERAPEUTICS INC	5,357,347	$16,286	6.1%	$2.72	+66.3%	COM	89854M101
CGEM	CULLINAN THERAPEUTICS INC	1,257,795	$15,320	5.7%	$16.54	-13.1%	COM	230031106
KROS	KEROS THERAPEUTICS INC	544,001	$8,612	3.2%	$51.97	0.0%	COM	492327101
—	PASSAGE BIO INC	9,256,953	$5,250	2.0%	$1.03	—	COM	702712100
—	ALLAKOS INC	3,628,144	$4,390	1.6%	$1.21	—	COM	01671P100
UPB	UPSTREAM BIO INC	240,042	$3,946	1.5%	$22.33	0.0%	COM	91678A107
DTIL	PRECISION BIOSCIENCES INC	766,051	$2,919	1.1%	$7.30	0.0%	COM NEW	74019P207
IBIO	IBIO INC	862,279	$2,113	0.8%	$1.77	+44.8%	CON NEW	451033708
CRBU	CARIBOU BIOSCIENCES INC	680,189	$1,082	0.4%	$2.05	-1.8%	COM	142038108
—	VOR BIOPHARMA INC	637,218	$707	0.3%	$1.11	—	COM	929033108
CNTA	CENTESSA PHARMACEUTICALS PLC	17,400	$291	0.1%	$11.30	—	SPONSORED ADS	152309100
NEUP	NEUPHORIA THERAPEUTICS INC	45,806	$157	0.1%	$3.53	0.0%	COM	64136E102
—	REPARE THERAPEUTICS INC	79,176	$104	0.0%	$1.31	—	COM	760273102